Increased renal vascular reactivity to ANG II after unilateral nephrectomy in the rat involves 20-HETE

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 291, Issue 4, 2006, Pages

  Joly, E ^a   Seqqat, R ^a   Flamion, B ^b   Caron, N ^a   Michel, A ^a   Imig, J D ^c   Kramp, R ^a  

^a UNIVERSITY OF MONS   (Belgium)

^b UNIVERSITY OF NAMUR   (Belgium)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Adapted kidney; Eicosanoids; HET0016; Indomethacin; Renal blood flow

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 20 HYDROXYICOSATETRAENOIC ACID; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME P450 4A; INDOMETACIN; LOSARTAN; PROSTANOID;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; UNINEPHRECTOMY; VASOCONSTRICTION;

ADAPTATION, PHYSIOLOGICAL; AMIDINES; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CYCLOOXYGENASE 1; CYCLOOXYGENASE INHIBITORS; CYTOCHROME P-450 ENZYME SYSTEM; DINOPROSTONE; HYDROXYEICOSATETRAENOIC ACIDS; IMIDAZOLES; INDOMETHACIN; LOSARTAN; MALE; MICROCIRCULATION; NEPHRECTOMY; NOREPINEPHRINE; PYRIDINES; RATS; RATS, WISTAR; RENAL CIRCULATION; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 33749346983     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00401.2005     Document Type: Article

References (44)

1. Alonso-Galicia M, Maier KG, Greene AS, Cowley AW, and Roman RJ. Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II. Am J Physiol Regul Integr Comp Physiol 283: R60-R68, 2002.
2. Arendshorst WJ, Brannstrom K, and Ruan X. Actions of angiotensin II on the renal microvasculature. J Am Soc Nephrol 10: S149-S161, 1999.
3. Boffa JJ and Arendshorst WJ. Maintenance of renal vascular reactivity contributes to acute renal failure during endotoxemic shock. J Am Soc Nephrol 16: 117-124, 2005.
4. Caron N, Dupuis V, Michel A, and Kramp R. Dose-response analysis of acute hypotensive and renal effects of atrial natriuretic peptide in the rat. Arch Int Pharmacodyn Ther 329: 379-396, 1995.
5. Caron N, El Hajjam A, Declèves AE, Joly E, Falck JR, and Kramp R. Changes in renal haemodynamics induced by indomethacin in the rat involve cytochrome P450 arachidonic acid-dependent epoxygenases. Clin Exp Pharmacol Physiol 31: 683-690, 2004.
6. Chatziantoniou C, Daniels FH, and Arendshorst WJ. Exaggerated renal vascular reactivity to angiotensin and thromboxane in young genetically hypertensive rats. Am J Physiol Renal Fluid Electrolyte Physiol 259: F372-F382, 1990.
7. Chatziantoniou C and Arendshorst WJ. Impaired ability of prostaglandins to buffer renal vasoconstriction in genetically hypertensive rats. Am J Physiol Renal Fluid Electrolyte Physiol 263: F573-F580, 1992.
8. Chatziantoniou C and Arendshorst WJ. Prostaglandin interactions with angiotensin, norepinephrine, and thromboxane in rat renal vasculature. Am J Physiol Renal Fluid Electrolyte Physiol 262: F68-F76, 1992.
9. Chatziantoniou C and Arendshorst WJ. Angiotensin receptor sites in renal vasculature of rats developing genetic hypertension. Am J Physiol Renal Fluid Electrolyte Physiol 265: F853-F862, 1993.
10. Chatziantoniou C, Ruan X, and Arendshorst WJ. Defective G protein activation of the cAMP pathway in rat kidney during genetic hypertension. Proc Natl Acad Sci USA 92: 2924-2928, 1995.
11. Cheng MK, McGiff JC, and Carroll MA. Renal arterial 20- hydroxyeicosatetraenoic acid levels: regulation by cyclooxygenase. Am J Physiol Renal Physiol 284: F474-F479, 2003.
12. Croft KD, McGiff JC, Sanchez-Mendoza A, and Carroll MA. Angiotensin II releases 20-HETE from rat renal microvessels. Am J Physiol Renal Physiol 279: F544-F551, 2000.
13. Cruz BV and Escalante B. Renal vascular interaction of angiotensin II and prostaglandins in renovascular hypertension. J Cardiovasc Pharmacol 34: 21-27, 1999.
14. Harris RC, and Martinez-Maldonado M. Angiotensin II-mediated renal injury. Miner Electrolyte Metab 21: 328-335, 1995.
15. Hayslett JP. Functional adaptation to reduction in renal mass. Physiol Rev 59: 137-164, 1979.
16. Hunyady L, Tian Y, Sandberg K, Balla T, and Catt KJ. Divergent conformational requirements for angiotensin II receptor internalization and signaling. Kidney Int 46: 1496-1498, 1994.
17. Imig JD and Navar LG. Afferent arteriolar response to arachidonic acid: involvement of metabolic pathways. Am J Physiol Renal Fluid Electrolyte Physiol 271: F87-F93, 1996.
18. Imig JD. Eicosanoid regulation of the renal vasculature. Am J Physiol Renal Physiol 279: F965-F981, 2000.
19. Imig JD, Falck JR, Wei S, and Capdevila JH. Enhanced renal microvascular responsiveness to angiotensin II in hypertension is ameliorated by the sulfonimide analog of 11, 12-epoxyeicosatrienoic acid. J Hypertens 19: 983-992, 2001.
20. Jacinto SM, Mullins JJ, and Mitchell KD. Enhanced renal vascular responsiveness to angiotensin II in hypertensive ren-2 transgenic rats. Am J Physiol Renal Physiol 276: F315-F322, 1999.
21. Joly E, Nonclercq D, Caron N, Mertens J, Flamion B, Toubeau G, Kramp R, and Bouby N. Differential regulation of angiotensin II receptors during renal injury and compensatory hypertrophy in the rat. Clin Exp Pharmacol Physiol 32: 241-248, 2005.
22. Kehl F, Cambj-Sapunar L, Maier KG, Miyata N, Kametani S, Okamoto H, Hudetz AG, Schulte ML, Zagorac D, Harder DR, and Roman RJ. 20-HETE contributes to the acute fall in cerebral blood flow after subarachnoid hemorrhage in the rat. Am J Physiol Heart Circ Physiol 282: H1556-H1565, 2002.
23. Kost CK and Jackson EK. Enhanced renal angiotensin II subtype 1 receptor responses in the spontaneously hypertensive rat. Hypertension 21: 420-431, 1993.
24. Kramp RA and Lenoir R. Distal permeability to urate and effects of benzofuran derivatives in the rat kidney. Am J Physiol 228: 875-883, 1975.
25. Kramp RA, Genard J, Fourmanoir P, Caron N, Laekeman G, and Herman A. Renal hemodynamics and blood flow autoregulation during acute cyclooxygenase inhibition in male rats. Am J Physiol Renal Fluid Electrolyte Physiol 268: F468-F479, 1995.
26. 2+ channel activity on renal hemodynamics during acute attenuation of NO synthesis in the rat. Am J Physiol Renal Physiol 278: F561-F569, 2000.
27. Marji JS, Wang MH, and Schwartzman ML. Cytochrome P-450A isoform expression and 20-HETE synthesis in renal preglomerular arteries. Am J Physiol Renal Physiol 283: F60-F67, 2002.
28. McGiff JC and Quilley J. 20-HETE and the kidney: resolution of old problems and new beginnings. Am J Physiol Regul Integr Comp Physiol 277: R607-R623, 1999.
29. Merrifield RB. Solid-phase peptide synthesis. I. The synthesis of a tetrapeptide. J Am Chem Soc 85: 2149-2154, 1963.
30. Michel B, Grima M, Coquard C, Welsch C, Barthelmebs M, and Imbs JL. Effects of dietary protein and uninephrectomy on renal angiotensin converting enzyme activity in the rat. Kidney Int 45: 1587-1592, 1994.
31. Miyata N, Taniguchi K, Seki T, Ishimoto T, Sato-Watanabe M, Yasuda Y, Doi M, Kametani S, Tomishima Y, Ueki T, Sato M, and Kame K. HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme. Br J Pharmacol 133: 325-329, 2001.
32. Navar LG, Inscho EW, Majid DSA, Imig JD, Harrisson-Bernard LM, and Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev 76: 425-536, 1996.
33. Purdy KE and Arendshorst WJ. Prostaglandins buffer ANG II-mediated increases in cytosolic calcium in preglomerular VSMC. Am J Physiol Renal Physiol 277: F850-F858, 1999.
34. Roman RJ. P450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82: 131-185, 2002.
35. Ruan X and Arendshorst WJ. Role of protein kinase C in angiotensin II-induced renal vasoconstriction in genetically hypertensive rats. Am J Physiol Renal Fluid Electrolyte Physiol 270: F945-F952, 1996.
36. Ruan X, Wagner C, Chatziantoniou C, Kurtz A, and Arendshorst WJ. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet. J Clin Invest 99: 1072-1081, 1997.
37. 1A receptor null mice. J Am Soc Nephrol 10: 2620-2630, 1999.
38. Sigmund CD. Genetic manipulation of the renin-angiotensin system : targeted expression of the renin-angiotensin system in the kidney. Am J Hypertens 14: 33S-37S, 2001.
39. Tank JE, Moe OW, Star RA, and Henrich WL. Differential regulation of rat glomerular and proximal tubular renin mRNA following uninephrectomy. Am J Physiol Renal Fluid Electrolyte Physiol 270: F776-F783, 1996.
40. Vyas SJ and Jackson EK. Angiotensin II: enhanced renal responsiveness in young genetically hypertensive rats. J Pharmacol Exp Ther 273: 768-777, 1995.
41. Wallenstein A, Zucker CL, and Fleiss JL. Some statistical methods useful in circulation research. Circ Res 47: 1-9, 1980.
42. Wang JL, Cheng HF, Zhang MZ, McKanna JA, and Harris RC. Selective increase of cyclooxygenase-2 expression in a model of renal ablation. Am J Physiol Renal Physiol 275: F613-F622, 1998.
43. Wolf G, Butzmann U, and Wenzel UO. The renin-angiotensin system and progression of renal disease: from hemodynamics to cell biology. Nephron Physiol 93: 3-13, 2003.
44. Zhang XZ, Qiu C, and Baylis C. Sensitivity of the segmental renal arterioles to angiotensin II in the aging rat. Mech Aging Dev 97: 183-192, 1997.